US Stock MarketDetailed Quotes

RIGL Rigel Pharmaceuticals

Watchlist
  • 1.140
  • +0.010+0.88%
Close Apr 23 16:00 ET
  • 1.120
  • -0.020-1.75%
Post 19:30 ET
199.96MMarket Cap-8142P/E (TTM)

Rigel Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
-2.79%116.88M
-30.20%35.79M
25.54%28.13M
-9.84%26.89M
55.78%26.07M
-19.43%120.24M
151.25%51.28M
4.02%22.41M
13.53%29.82M
-79.34%16.74M
Operating revenue
5.00%159.65M
-21.19%48.07M
31.10%39.59M
-9.84%26.89M
55.78%26.07M
-9.18%152.05M
58.08%61M
40.18%30.2M
13.53%29.82M
-79.34%16.74M
Cost of revenue
306.52%7.11M
1,008.19%3.79M
407.20%1.27M
3.76%1.08M
707.44%977K
61.50%1.75M
-29.77%342K
65.56%250K
703.10%1.04M
-61.71%121K
Gross profit
-7.36%109.77M
-37.17%32M
21.24%26.87M
-10.33%25.81M
51.04%25.09M
-20.02%118.49M
155.68%50.94M
3.59%22.16M
10.12%28.78M
-79.41%16.61M
Operating expense
-24.58%130.26M
-36.82%30.04M
-22.76%31.33M
-25.56%31.08M
-11.79%37.82M
9.93%172.72M
25.70%47.54M
-1.49%40.56M
6.54%41.75M
10.09%42.88M
Selling and administrative expenses
-5.97%105.74M
-16.54%26.85M
-4.02%24.86M
-2.50%26.31M
1.20%27.73M
22.37%112.45M
31.23%32.17M
13.20%25.9M
20.57%26.98M
23.87%27.4M
Research and development costs
-59.31%24.52M
-79.26%3.19M
-55.85%6.48M
-67.68%4.77M
-34.80%10.09M
-7.61%60.27M
15.49%15.37M
-19.86%14.67M
-12.14%14.77M
-8.04%15.47M
Operating profit
62.21%-20.49M
-42.16%1.97M
75.74%-4.47M
59.38%-5.27M
51.54%-12.73M
-504.23%-54.23M
118.99%3.4M
6.99%-18.4M
0.64%-12.97M
-162.89%-26.26M
Net non-operating interest income expense
-52.17%-4.6M
-81.27%-1.23M
-93.53%-1.23M
-152.94%-1.33M
31.50%-811K
37.19%-3.02M
47.16%-678K
51.34%-634K
69.76%-527K
-144.63%-1.18M
Non-operating interest income
232.16%2.27M
58.04%678K
250.00%672K
1,159.52%529K
1,771.43%393K
1,355.32%684K
2,581.25%429K
1,271.43%192K
162.50%42K
2,000.00%21K
Non-operating interest expense
85.38%6.87M
72.27%1.91M
129.90%1.9M
227.24%1.86M
-0.08%1.2M
-23.72%3.71M
-14.78%1.11M
-37.28%826K
-67.65%569K
148.45%1.21M
Other net income (expense)
62.51%-1.32M
Special income (charges)
--0
----
----
----
----
62.51%-1.32M
----
----
----
----
-Less:Restructuring and merger&acquisition
--0
----
----
----
----
-62.51%1.32M
----
----
----
----
Income before tax
57.16%-25.09M
-47.39%737K
70.10%-5.69M
51.08%-6.6M
50.68%-13.54M
-238.40%-58.57M
106.17%1.4M
9.73%-19.04M
8.78%-13.49M
-166.50%-27.45M
Income tax
0
0
Net income
57.16%-25.09M
-47.39%737K
70.10%-5.69M
51.08%-6.6M
50.68%-13.54M
-226.97%-58.57M
106.19%1.4M
9.14%-19.04M
2.38%-13.49M
-169.48%-27.45M
Net income continuous Operations
57.16%-25.09M
-47.39%737K
70.10%-5.69M
51.08%-6.6M
50.68%-13.54M
-226.97%-58.57M
106.19%1.4M
9.14%-19.04M
2.38%-13.49M
-169.48%-27.45M
Minority interest income
Net income attributable to the parent company
57.16%-25.09M
-47.39%737K
70.10%-5.69M
51.08%-6.6M
50.68%-13.54M
-226.97%-58.57M
106.19%1.4M
9.14%-19.04M
2.38%-13.49M
-169.48%-27.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
57.16%-25.09M
-47.39%737K
70.10%-5.69M
51.08%-6.6M
50.68%-13.54M
-226.97%-58.57M
106.19%1.4M
9.14%-19.04M
2.38%-13.49M
-169.48%-27.45M
Basic earnings per share
58.82%-0.14
0.00%0.01
72.73%-0.03
50.00%-0.04
50.00%-0.08
-209.09%-0.34
107.69%0.01
8.33%-0.11
0.00%-0.08
-169.57%-0.16
Diluted earnings per share
58.82%-0.14
0.00%0.01
72.73%-0.03
50.00%-0.04
50.00%-0.08
-209.09%-0.34
107.69%0.01
8.33%-0.11
0.00%-0.08
-172.73%-0.16
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue -2.79%116.88M-30.20%35.79M25.54%28.13M-9.84%26.89M55.78%26.07M-19.43%120.24M151.25%51.28M4.02%22.41M13.53%29.82M-79.34%16.74M
Operating revenue 5.00%159.65M-21.19%48.07M31.10%39.59M-9.84%26.89M55.78%26.07M-9.18%152.05M58.08%61M40.18%30.2M13.53%29.82M-79.34%16.74M
Cost of revenue 306.52%7.11M1,008.19%3.79M407.20%1.27M3.76%1.08M707.44%977K61.50%1.75M-29.77%342K65.56%250K703.10%1.04M-61.71%121K
Gross profit -7.36%109.77M-37.17%32M21.24%26.87M-10.33%25.81M51.04%25.09M-20.02%118.49M155.68%50.94M3.59%22.16M10.12%28.78M-79.41%16.61M
Operating expense -24.58%130.26M-36.82%30.04M-22.76%31.33M-25.56%31.08M-11.79%37.82M9.93%172.72M25.70%47.54M-1.49%40.56M6.54%41.75M10.09%42.88M
Selling and administrative expenses -5.97%105.74M-16.54%26.85M-4.02%24.86M-2.50%26.31M1.20%27.73M22.37%112.45M31.23%32.17M13.20%25.9M20.57%26.98M23.87%27.4M
Research and development costs -59.31%24.52M-79.26%3.19M-55.85%6.48M-67.68%4.77M-34.80%10.09M-7.61%60.27M15.49%15.37M-19.86%14.67M-12.14%14.77M-8.04%15.47M
Operating profit 62.21%-20.49M-42.16%1.97M75.74%-4.47M59.38%-5.27M51.54%-12.73M-504.23%-54.23M118.99%3.4M6.99%-18.4M0.64%-12.97M-162.89%-26.26M
Net non-operating interest income expense -52.17%-4.6M-81.27%-1.23M-93.53%-1.23M-152.94%-1.33M31.50%-811K37.19%-3.02M47.16%-678K51.34%-634K69.76%-527K-144.63%-1.18M
Non-operating interest income 232.16%2.27M58.04%678K250.00%672K1,159.52%529K1,771.43%393K1,355.32%684K2,581.25%429K1,271.43%192K162.50%42K2,000.00%21K
Non-operating interest expense 85.38%6.87M72.27%1.91M129.90%1.9M227.24%1.86M-0.08%1.2M-23.72%3.71M-14.78%1.11M-37.28%826K-67.65%569K148.45%1.21M
Other net income (expense) 62.51%-1.32M
Special income (charges) --0----------------62.51%-1.32M----------------
-Less:Restructuring and merger&acquisition --0-----------------62.51%1.32M----------------
Income before tax 57.16%-25.09M-47.39%737K70.10%-5.69M51.08%-6.6M50.68%-13.54M-238.40%-58.57M106.17%1.4M9.73%-19.04M8.78%-13.49M-166.50%-27.45M
Income tax 00
Net income 57.16%-25.09M-47.39%737K70.10%-5.69M51.08%-6.6M50.68%-13.54M-226.97%-58.57M106.19%1.4M9.14%-19.04M2.38%-13.49M-169.48%-27.45M
Net income continuous Operations 57.16%-25.09M-47.39%737K70.10%-5.69M51.08%-6.6M50.68%-13.54M-226.97%-58.57M106.19%1.4M9.14%-19.04M2.38%-13.49M-169.48%-27.45M
Minority interest income
Net income attributable to the parent company 57.16%-25.09M-47.39%737K70.10%-5.69M51.08%-6.6M50.68%-13.54M-226.97%-58.57M106.19%1.4M9.14%-19.04M2.38%-13.49M-169.48%-27.45M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 57.16%-25.09M-47.39%737K70.10%-5.69M51.08%-6.6M50.68%-13.54M-226.97%-58.57M106.19%1.4M9.14%-19.04M2.38%-13.49M-169.48%-27.45M
Basic earnings per share 58.82%-0.140.00%0.0172.73%-0.0350.00%-0.0450.00%-0.08-209.09%-0.34107.69%0.018.33%-0.110.00%-0.08-169.57%-0.16
Diluted earnings per share 58.82%-0.140.00%0.0172.73%-0.0350.00%-0.0450.00%-0.08-209.09%-0.34107.69%0.018.33%-0.110.00%-0.08-172.73%-0.16
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg